Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-23T08:16:30.941Z Has data issue: false hasContentIssue false

30 - Experimental models of muscle diseases

Published online by Cambridge University Press:  04 November 2009

Anu Suomalainen
Affiliation:
Department of Neurology Helsinki University Central Hospital Haartmaninkatu 4 00290 Helsinki Finland
Katja E. Peltola Mjosund
Affiliation:
Programme of Neurosciences and Department of Neurology University of Helsinki Helsinki University Central Hospital Biomedicum Helsinki Haartmaninkatu 8 00290 Helsinki Finland
Anders Paetau
Affiliation:
Department of Pathology Helsinki University Central Hospital Haartmaninkatu 3 00290 Helsinki Finland
Carina Wallgren-Pettersson
Affiliation:
Department of Medical Genetics University of Helsinki and Folkhälsan Institute of Genetics Haartmaninkatu 8 00290 Helsinki Finland
Turgut Tatlisumak
Affiliation:
Helsinki University Central Hospital
Marc Fisher
Affiliation:
University of Massachusetts Medical School
Get access

Summary

Introduction

The body harbors a complex muscle system, in which individual muscles can be identified by their size, position, shape, function, and attachments. The skeletal muscles are striated and voluntary, highly specialized muscles, which attach to bones via tendons, have a specific anatomical position and innervation, and move the skeleton. Cardiac muscle is of a unique kind, striated and of involuntary type. The smooth muscle is also involuntary, and moves the bowel, modifies vessels, and constricts the bladder, to name just a few of its functions. By muscle diseases, one usually means diseases affecting the skeletal muscle, and experimental research on this muscle type is the focus of this chapter.

Diseases of muscle may result from a range of defects, from developmental defects to those in structural backbone proteins and energy metabolism. Research clarifying the nature of defects in muscle diseases has been a valuable source of information for understanding normal muscle function. Experimental muscle models can be created to study the normal function of a protein, or to study the effect of a gene mutation to clarify disease pathogenesis. Alternatively, interesting phenotypes may have arisen spontaneously in experimental animal lines, and their characterization may bring new knowledge of muscle function and diseases. Most experimental procedures concerning muscle diseases are common routine techniques of molecular biology and genetics. Therefore, in this chapter, we have concentrated on introducing those aspects of experimental muscle research that are specific for the tissue and its diseases.

Type
Chapter
Information
Handbook of Experimental Neurology
Methods and Techniques in Animal Research
, pp. 544 - 561
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Donner, K, Sandbacka, M, Lehtokari, VL, Wallgren-Pettersson, C, Pelin, K. Complete genomic structure of the human nebulin gene and identification of alternatively spliced transcripts. Eur. J. Hum. Genet. 2004, 12: 744–751.CrossRefGoogle ScholarPubMed
Udd, B, Partanen, J, Halonen, P, et al. Tibial muscular dystrophy: late adult-onset distal myopathy in 66 Finnish patients. Arch. Neurol. 1993, 50: 604–608.CrossRefGoogle ScholarPubMed
Hackman, P, Vihola, A, Haravuori, H, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am. J. Hum. Genet. 2002, 71: 492–500.CrossRefGoogle ScholarPubMed
Hackman, JP, Vihola, AK, Udd, AB. The role of titin in muscular disorders. Ann. Med. 2003, 35: 434–441.CrossRefGoogle ScholarPubMed
Mankoo, BS, Collins, NS, Ashby, P, et al. Mox2 is a component of the genetic hierarchy controlling limb muscle development. Nature 1999, 400: 69–73.Google ScholarPubMed
Spangenburg, EE, Booth, FW. Molecular regulation of individual skeletal muscle fibre types. Acta Physiol. Scand. 2003, 178: 413–424.CrossRefGoogle ScholarPubMed
Baldwin, KM, Klinkerfuss, GH, Terjung, RL, Mole, PA, Holloszy, JO. Respiratory capacity of white, red, and intermediate muscle: adaptative response to exercise. Am. J. Physiol. 1972, 222: 373–378.Google Scholar
Essen, B, Jansson, E, Henriksson, J, Taylor, AW, Saltin, B. Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol. Scand. 1975, 95: 153–165.CrossRefGoogle ScholarPubMed
Smerdu, V, Erzen, I. Dynamic nature of fibre-type specific expression of myosin heavy chain transcripts in 14 different human skeletal muscles. J. Muscle Res. Cell Motil. 2001, 22: 647–655.CrossRefGoogle ScholarPubMed
Rhee, HS, Lucas, CA, Hoh, JF. Fiber types in rat laryngeal muscles and their transformations after denervation and reinnervation. J. Histochem. Cytochem. 2004, 52: 581–590.CrossRefGoogle ScholarPubMed
Soukup, T, Zacharova, G, Smerdu, V. Fibre type composition of soleus and extensor digitorum longus muscles in normal female inbred Lewis rats. Acta Histochem. 2002, 104: 399–405.CrossRefGoogle ScholarPubMed
Sipila, I, Simell, O, Rapola, J, Sainio, K, Tuuteri, L. Gyrate atrophy of the choroid and retina with hyperornithinemia: tubular aggregates and type 2 fiber atrophy in muscle. Neurology 1979, 29: 996–1005.CrossRefGoogle ScholarPubMed
Booth, FW, Thomason, DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol. Rev. 1991, 71: 541–585.CrossRefGoogle ScholarPubMed
Wang, YX, Zhang, CL, Yu, RT, et al. Regulation of muscle fiber type and running endurance by PPAR delta. PLoS Biol 2004, 2: e294.CrossRefGoogle Scholar
Pette, D. Training effects on the contractile apparatus. Acta Physiol. Scand. 1998, 162: 367–376.CrossRefGoogle ScholarPubMed
Olson, EN, Williams, RS. Remodeling muscles with calcineurin. BioEssays 2000, 22: 510–519.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Jarvis, JC, Mokrusch, T, Kwende, MM, Sutherland, H, Salmons, S. Fast-to-slow transformation in stimulated rat muscle. Muscle Nerve 1996, 19: 1469–1475.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Hood, DA. Invited review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 2001, 90: 1137–1157.CrossRefGoogle ScholarPubMed
Pellegrino, MA, Canepari, M, Rossi, R, et al. Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J. Physiol. 2003, 546: 677–689.CrossRefGoogle ScholarPubMed
Agbulut, O, Li, Z, Mouly, V, Butler-Browne, GS. Analysis of skeletal and cardiac muscle from desmin knock-out and normal mice by high resolution separation of myosin heavy-chain isoforms. Biol. Cell 1996, 88: 131–135.CrossRefGoogle ScholarPubMed
Shoubridge, EA, Johns, T, Boulet, L. Use of myoblast cultures to study mitochondrial myopathies. Methods Enzymol. 1995, 264: 465–475.CrossRefGoogle Scholar
Martinuzzi, A, Askanas, V, Kobayashi, T, Engel, WK, Di Mauro, S. Expression of muscle-gene-specific isozymes of phosphorylase and creatine kinase in innervated cultured human muscle. J. Cell Biol. 1986, 103: 1423–1429.CrossRefGoogle ScholarPubMed
Sasarman, F, Karpati, G, Shoubridge, EA. Nuclear genetic control of mitochondrial translation in skeletal muscle revealed in patients with mitochondrial myopathy. Hum. Mol. Genet. 2002, 11: 1669–1681.CrossRefGoogle ScholarPubMed
Clark, KM, Watt, DJ, Lightowlers, RN, et al. SCID mice containing muscle with human mitochondrial DNA mutations: an animal model for mitochondrial DNA defects. J. Clin. Invest. 1998, 102: 2090–2095.CrossRefGoogle ScholarPubMed
Davis, RL, Weintraub, H, Lassar, AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51: 987–1000.CrossRefGoogle ScholarPubMed
Edmondson, DG, Olson, EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Devel. 1989, 3: 628–640.CrossRefGoogle ScholarPubMed
Wright, WE, Sassoon, DA, Lin, VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 1989, 56: 607–617.CrossRefGoogle Scholar
Braun, T, Buschhausen-Denker, G, Bober, E, Tannich, E, Arnold, HH. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 1989, 8: 701–709.Google ScholarPubMed
Braun, T, Bober, E, Winter, B, Rosenthal, N, Arnold, HH. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 1990, 9: 821–831.Google ScholarPubMed
Blau, HM, Pavlath, GK, Hardeman, EC, et al. Plasticity of the differentiated state. Science 1985, 230: 758–766.CrossRefGoogle ScholarPubMed
Richler, C, Yaffe, D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Devel. Biol. 1970, 23: 1–22.CrossRefGoogle ScholarPubMed
See http://www.lgcpromochem.com/atcc/.
Miller, AD, Rosman, GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989, 7: 980–982, 984–986, 989–990.Google ScholarPubMed
Miller, AD. Progress toward human gene therapy. Blood 1990, 76: 271–278.Google ScholarPubMed
Miller, AD, Miller, DG, Garcia, JV, Lynch, CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 1993, 217: 581–599.CrossRefGoogle ScholarPubMed
Hitoshi, Y, Lorens, J, Kitada, SI, et al. Toso, a cell surface-specific regulator of Fas-induced apoptosis in T cells. Immunity 1998, 8: 461–471.CrossRefGoogle Scholar
Nolan, GP, Shatzman, AR. Expression vectors and delivery systems. Curr. Opin. Biotechnol. 1998, 9: 447–450.CrossRefGoogle ScholarPubMed
See http://www.stanford.edu/group/nolan/retroviral_systems/retsys.html.
Gunning, P, Ponte, P, Blau, H, Kedes, L. Alpha-skeletal and alpha-cardiac actin genes are coexpressed in adult human skeletal muscle and heart. Mol. Cell Biol. 1983, 3: 1985–1995.CrossRefGoogle ScholarPubMed
Shani, M. Tissue-specific and developmentally regulated expression of a chimeric actin-globin gene in transgenic mice. Mol. Cell Biol. 1986, 6: 2624–2631.CrossRefGoogle ScholarPubMed
Brennan, KJ, Hardeman, EC. Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J. Biol. Chem. 1993, 268: 719–725.Google ScholarPubMed
Song, Q, Young, KB, Chu, G, et al. Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodeling. FASEB J. 2004, 18: 974–976.CrossRefGoogle ScholarPubMed
Walsh, FS, Hobbs, C, Wells, DJ, Slater, CR, Fazeli, S. Ectopic expression of NCAM in skeletal muscle of transgenic mice results in terminal sprouting at the neuromuscular junction and altered structure but not function. Mol. Cell Neurosci. 2000, 15: 244–261.CrossRefGoogle Scholar
Tyynismaa, H, Sembongi, H, Bokori-Brown, M, et al. Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum. Mol. Genet. 2004.CrossRefGoogle ScholarPubMed
Levak-Frank, S, Radner, H, Walsh, A, et al. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 1995, 96: 976–986.CrossRefGoogle ScholarPubMed
Musaro, A, McCullagh, K, Paul, A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genet. 2001, 27: 195–200.CrossRefGoogle ScholarPubMed
Shani, M. Tissue-specific expression of rat myosin light-chain 2 gene in transgenic mice. Nature 1985, 314: 283–286.CrossRefGoogle ScholarPubMed
Rindt, H, Knotts, S, Robbins, J. Segregation of cardiac and skeletal muscle-specific regulatory elements of the beta-myosin heavy chain gene. Proc. Natl Acad. Sci. USA 1995, 92: 1540–1544.CrossRefGoogle ScholarPubMed
Salminen, M, Maire, P, Concordet, JP, et al. Fast-muscle-specific expression of human aldolase A transgenes. Mol. Cell Biol. 1994, 14: 6797–6808.CrossRefGoogle ScholarPubMed
Yamashita, T, Kasai, N, Miyoshi, I, et al. High level expression of human alpha-fetoprotein in transgenic mice. Biochem. Biophys. Res. Commun. 1993, 191: 715–720.CrossRefGoogle ScholarPubMed
Isoda, K, Kamezawa, Y, Tada, N, Sato, M, Ohsuzu, F. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1 alpha. J. Card. Fail. 2001, 7: 355–364.CrossRefGoogle Scholar
Imai, S, Kaksonen, M, Raulo, E, et al. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol. 1998, 143: 1113–1128.CrossRefGoogle Scholar
Ekstrand, MI, Falkenberg, M, Rantanen, A, et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 2004, 13: 935–944.CrossRefGoogle ScholarPubMed
Voet, T, Schoenmakers, E, Carpentier, S, Labaere, C, Marynen, P. Controlled transgene dosage and PAC-mediated transgenesis in mice using a chromosomal vector. Genomics 2003, 82: 596–605.CrossRefGoogle ScholarPubMed
Grifone, R, Laclef, C, Spitz, F, et al. Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol. Cell Biol. 2004, 24: 6253–6267.CrossRefGoogle ScholarPubMed
Lerman, I, Harrison, BC, Freeman, K, et al. Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J. Appl. Physiol. 2002, 92: 2245–2255.CrossRefGoogle ScholarPubMed
Meyer, OA, Tilson, HA, Byrd, WC, Riley, MT. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1: 233–236.Google ScholarPubMed
Derave, W, Bosch, L, Lemmens, G, et al. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol. Dis. 2003, 13: 264–272.CrossRefGoogle Scholar
Thifault, S, Girouard, N, Lalonde, R. Climbing sensorimotor skills in Lurcher mutant mice. Brain Res. Bull. 1996, 41: 385–390.CrossRefGoogle ScholarPubMed
Lalonde, R, Kim, HD, Fukuchi, K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice. Neurosci. Lett. 2004, 369: 156–161.CrossRefGoogle ScholarPubMed
Hara, H, Nolan, PM, Scott, MO, et al. Running endurance abnormality in mdx mice. Muscle Nerve 2002, 25: 207–211.CrossRefGoogle ScholarPubMed
Joya, JE, Kee, AJ, Nair-Shalliker, V, et al. Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism. Hum. Mol. Genet. 2004, 13: 2633–2645.CrossRefGoogle Scholar
Swallow, JG, Garland, T Jr, Carter, PA, Zhan, WZ, Sieck, GC. Effects of voluntary activity and genetic selection on aerobic capacity in house mice (Mus domesticus). J. Appl. Physiol. 1998, 84: 69–76.CrossRefGoogle Scholar
Fernando, P, Bonen, A, Hoffman-Goetz, L. Predicting submaximal oxygen consumption during treadmill running in mice. Can. J. Physiol. Pharmacol. 1993, 71: 854–857.CrossRefGoogle ScholarPubMed
Allen, DL, Harrison, BC, Maass, A, et al. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J. Appl. Physiol. 2001, 90: 1900–1908.CrossRefGoogle ScholarPubMed
Lightfoot, JT, Turner, MJ, Daves, M, Vordermark, A, Kleeberger, SR. Genetic influence on daily wheel running activity level. Physiol. Genomics 2004.CrossRefGoogle ScholarPubMed
Lightfoot, JT, Turner, MJ, Debate, KA, Kleeberger, SR. Interstrain variation in murine aerobic capacity. Med. Sci. Sports Exerc. 2001, 33: 2053–2057.CrossRefGoogle ScholarPubMed
Yang, Q, Osinska, H, Klevitsky, R, Robbins, J. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. J. Mol. Cell. Cardiol. 2001, 33: 1649–1658.CrossRefGoogle ScholarPubMed
Bao, S, Garvey, WT. Exercise in transgenic mice overexpressing GLUT4 glucose transporters: effects on substrate metabolism and glycogen regulation. Metabolism 1997, 46: 1349–1357.CrossRefGoogle ScholarPubMed
Nair-Shalliker, V, Kee, AJ, Joya, JE, et al. Myofiber adaptational response to exercise in a mouse model of nemaline myopathy. Muscle Nerve 2004, 30: 470–480.CrossRefGoogle Scholar
Hellam, DC, Podolsky, RJ. Force measurements in skinned muscle fibres. J. Physiol. 1969, 200: 807–819.CrossRefGoogle ScholarPubMed
Ford, , Podolsky, RJ. Intracellular calcium movements in skinned muscle fibres. J. Physiol. 1972, 223: 21–33.CrossRefGoogle ScholarPubMed
Childers, MK, McDonald, KS. Regulatory light chain phosphorylation increases eccentric contraction-induced injury in skinned fast-twitch fibers. Muscle Nerve 2004, 29: 313–317.CrossRefGoogle ScholarPubMed
Dubowitz, V. Therapeutic possibilities in muscular dystrophy: the hope versus the hype. Neuromusc. Disord. 2002, 12: 113–116.CrossRefGoogle ScholarPubMed
Dubowitz, V. Therapeutic efforts in Duchenne muscular dystrophy: the need for a common language between basic scientists and clinicians. Neuromusc. Disord. 2004, 14: 451–455.CrossRefGoogle ScholarPubMed
Perkins, KJ, Davies, KE. The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromusc. Disord. 2002, 12 (Suppl. 1): S78–S89.CrossRefGoogle ScholarPubMed
Nowak, KJ, Wattanasirichaigoon, D, Goebel, HH, et al. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nature Genet. 1999, 23: 208–212.CrossRefGoogle ScholarPubMed
Agrawal, PB, Strickland, CD, Midgett, C, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations. Ann. Neurol. 2004, 56: 86–96.CrossRefGoogle ScholarPubMed
Corbett, MA, Robinson, CS, Dunglison, GF, et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum. Mol. Genet. 2001, 10: 317–328.CrossRefGoogle Scholar
Dunckley, MG, Manoharan, M, Villiet, P, Eperon, IC, Dickson, G. Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 1998, 7: 1083–1090.CrossRefGoogle ScholarPubMed
Wilton, SD, Lloyd, F, Carville, K, et al. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromusc. Disord. 1999, 9: 330–338.CrossRefGoogle ScholarPubMed
Bertoni, C, Lau, C, Rando, TA. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum. Mol. Genet. 2003, 12: 1087–1099.CrossRefGoogle ScholarPubMed
Goyenvalle, A, Vulin, A, Fougerousse, F, et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004.CrossRefGoogle ScholarPubMed
Huard, J, Cao, B, Qu-Petersen, Z. Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res. Part C Embryo Today 2003, 69: 230–237.CrossRefGoogle ScholarPubMed
Carter, JE, Schuchman, EH. Gene therapy for neurodegenerative diseases: fact or fiction? Br. J. Psychiatr. 2001, 178: 392–394.CrossRefGoogle ScholarPubMed
Skuk, D, Goulet, M, Roy, B, Tremblay, JP. Myoblast transplantation in whole muscle of nonhuman primates. J. Neuropathol. Exp. Neurol. 2000, 59: 197–206.CrossRefGoogle ScholarPubMed
Skuk, D, Tremblay, JP. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J. Muscle Res. Cell Motil. 2003, 24: 285–300.CrossRefGoogle ScholarPubMed
Partridge, TA, Morgan, JE, Coulton, GR, Hoffman, EP, Kunkel, LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989, 337: 176–179.CrossRefGoogle ScholarPubMed
Gussoni, E, Pavlath, GK, Lanctot, AM, et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992, 356: 435–438.CrossRefGoogle ScholarPubMed
Karpati, G, Ajdukovic, D, Arnold, D, et al. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 1993, 34: 8–17.CrossRefGoogle ScholarPubMed
Mendell, JR, Kissel, JT, Amato, AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl. J. Med. 1995, 333: 832–838.CrossRefGoogle ScholarPubMed
Sampaolesi, M, Torrente, Y, Innocenzi, A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003, 301: 487–492.CrossRefGoogle ScholarPubMed
Thioudellet, C, Blot, S, Squiban, P, Fardeau, M, Braun, S. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. I. Rationale. Neuromusc. Disord. 2002, 12 (Suppl. 1): S49–S51.CrossRefGoogle ScholarPubMed
Romero, NB, Benveniste, O, Payan, C, et al. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. II. Clinical protocol. Neuromusc. Disord. 2002, 12 (Suppl. 1): S45–S48.CrossRefGoogle ScholarPubMed
Fardeau, M. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. III. Ethical considerations. Neuromusc. Disord. 2002, 12 (Suppl. 1): S52–S54.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Experimental models of muscle diseases
    • By Anu Suomalainen, Department of Neurology Helsinki University Central Hospital Haartmaninkatu 4 00290 Helsinki Finland, Katja E. Peltola Mjosund, Programme of Neurosciences and Department of Neurology University of Helsinki Helsinki University Central Hospital Biomedicum Helsinki Haartmaninkatu 8 00290 Helsinki Finland, Anders Paetau, Department of Pathology Helsinki University Central Hospital Haartmaninkatu 3 00290 Helsinki Finland, Carina Wallgren-Pettersson, Department of Medical Genetics University of Helsinki and Folkhälsan Institute of Genetics Haartmaninkatu 8 00290 Helsinki Finland
  • Edited by Turgut Tatlisumak, Marc Fisher
  • Book: Handbook of Experimental Neurology
  • Online publication: 04 November 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541742.030
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Experimental models of muscle diseases
    • By Anu Suomalainen, Department of Neurology Helsinki University Central Hospital Haartmaninkatu 4 00290 Helsinki Finland, Katja E. Peltola Mjosund, Programme of Neurosciences and Department of Neurology University of Helsinki Helsinki University Central Hospital Biomedicum Helsinki Haartmaninkatu 8 00290 Helsinki Finland, Anders Paetau, Department of Pathology Helsinki University Central Hospital Haartmaninkatu 3 00290 Helsinki Finland, Carina Wallgren-Pettersson, Department of Medical Genetics University of Helsinki and Folkhälsan Institute of Genetics Haartmaninkatu 8 00290 Helsinki Finland
  • Edited by Turgut Tatlisumak, Marc Fisher
  • Book: Handbook of Experimental Neurology
  • Online publication: 04 November 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541742.030
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Experimental models of muscle diseases
    • By Anu Suomalainen, Department of Neurology Helsinki University Central Hospital Haartmaninkatu 4 00290 Helsinki Finland, Katja E. Peltola Mjosund, Programme of Neurosciences and Department of Neurology University of Helsinki Helsinki University Central Hospital Biomedicum Helsinki Haartmaninkatu 8 00290 Helsinki Finland, Anders Paetau, Department of Pathology Helsinki University Central Hospital Haartmaninkatu 3 00290 Helsinki Finland, Carina Wallgren-Pettersson, Department of Medical Genetics University of Helsinki and Folkhälsan Institute of Genetics Haartmaninkatu 8 00290 Helsinki Finland
  • Edited by Turgut Tatlisumak, Marc Fisher
  • Book: Handbook of Experimental Neurology
  • Online publication: 04 November 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541742.030
Available formats
×